Real-time enrollment status for this transcatheter aortic valve replacement (tavr) clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:17 PM UTC
| NCT Number | NCT07556523 |
| Recruiting Status | Recruiting |
| Condition | Transcatheter Aortic Valve Replacement (TAVR) |
| Phase | PHASE4 |
| Target Enrollment | 126 participants |
| Active Locations | 1 sites in the US |
| Sponsor | David Lyubashevsky |
| Last Updated on CT.gov | April 29, 2026 (Apr 29, 2026) |
As of July 19, 2026: Clinical trial NCT07556523 is currently recruiting participants. This phase4 study for transcatheter aortic valve replacement (tavr) is actively seeking new participants at 1 location across the United States. The study is sponsored by David Lyubashevsky. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07556523 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07556523 was last updated Apr 29, 2026 (April 29, 2026). HelloStudys verifies this status automatically.